跳至主要内容
临床试验/ITMCTR2000002928
ITMCTR2000002928尚未招募1 期

Clinical study for the effect of Combinative Treatment of Heart and Spleen on intestinal flora in patients with non-st-segment elevation myocardial infarction with qi deficiency and blood stas

Xiyuan Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • (1) consistent with NSTEMI diagnosis;
  • (2) Aged 40 to 60 years;
  • (3) patients should meet the diagnosis of TCM qi deficiency and blood stasis syndrome;
  • (4) the cardiac function I and II level (NYHA heart function classification);
  • (5) the patients did not take antibiotics, steroids, laxatives, antidiarrheals or probiotics within 3 months before enrollment;
  • (6) the subject is informed and signs the informed consent voluntarily;
  • (7) patients in cardiovascular ward.

排除标准

  • (1) renal insufficiency, male serum creatinine >2.5 mg/dl (>220umo/l) female serum creatinine 2.0 mg/dl (>175umo/l);
  • (2) significant liver disease or ALT and AST were 3 times higher than the normal upper limit;
  • (3) after control, systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg (patients should sit for at least 5 minutes before blood pressure measurement);
  • (4) diabetic patients with random blood glucose >=13.7mmol/L or hemoglobin ALC >=9.5%;
  • (5) women who are pregnant or preparing to be pregnant, women who are nursing, and those who are allergic to the known components of the drug;
  • (6) patients with acute cerebrovascular disease;
  • (7) malignant tumor or life expectancy of the patient is less than 1 year;
  • (8) patients with severe hematopoietic system diseases;
  • (9) severe mental illness.

研究者

相似试验